FdaApplication

ANDA 215664

Back to search

Identifiers

Properties

PropertyValue
applicant_nameOSMOTICA PHARMACEUTICAL US LLC
application_typeANDA
approval_date2024-10-22

Products (3)

ProductActive ingredientStrengthDosage form
CARBAMAZEPINECARBAMAZEPINE100MGTABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINECARBAMAZEPINE200MGTABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINECARBAMAZEPINE400MGTABLET, EXTENDED RELEASE;ORAL

3 products